Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a class of antihyperglycemic drugs, are used to manage type 2 diabetes mellitus, but also have pleiotropic effects on protecting against age-related oxidative stress, cellular senescence, and chronic inflammation. Here, GLP1R is linked to type 2 diabetes mellitus.